DROPA Bronchialpastillen neue Formel, Lutschpastillen

7680689560014 CH-68956 Tabletten
DROPA Bronchialpastillen neue Formel, Lutschpastillen
DROPA Bronchialpastillen neue Formel, Lutschpastillen
DROPA Bronchialpastillen neue Formel, Lutschpastillen
1 / 3
google

Article details

Package size
40
Selling units
40
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
06/10/2025
Patient information leaflet
Français
06/10/2025
Patient information leaflet
Italien
06/10/2025

Detailed composition

Substance Quantity Type Category
(N/A)
3.1 MG Substance Wirkstoff (Principe actif)
(N/A)
1.4 MG Substance Wirkstoff (Principe actif)
(N/A)
3.9 MG Substance Wirkstoff (Principe actif)
(N/A)
1.4 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
60.0 MG Substance Wirkstoff (Principe actif)
(N/A)
129.6 MG Substance Wirkstoff (Principe actif)
(N/A)
716.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Authorization holder

DR. BÄHLER DROPA AG

8045 Zürich

Authorization information

Swissmedic authorization number
68956
Drug name
DROPA Bronchialpastillen neue Formel, Lutschpastillen
Galenic form
LUTT
ATC Code
R05FB02
Authorization status
Z
Authorization category
Category C
Dispensing category
E
First authorization
21/06/2022
Authorization expiration date
31/12/9999
IT Number
03.02.0.
Domain
Human medicine
Field of application
Bei Erkältungshusten

Package details

Description (FR)
DROPA pastilles bronches nouv formule 40 pce
Description (DE)
DROPA Bronchialpastillen neue Formel 40 Stk
Market launch
21/06/2022
Narcotic (BTM)
No